Skip to main content

Month: May 2020

Green Plains Reports First Quarter 2020 Financial Results

Results for the First Quarter of 2020:Net loss attributable to the company of $16.4 million, or $(0.47) per diluted share including a non-cash goodwill impairment and an adjustment in income tax benefits related to the CARES ActAdjusted EBITDA of $2.7 millionCash, cash equivalents and restricted cash of $205.5 million; $260.8 million available under working capital facilitiesRepurchased approximately 0.9 million shares totaling $11.5 million during the quarterHigh protein ingredient production began at Shenandoah biorefineryGreen Plains Cattle Company achieved record results during the quarterOMAHA, Neb., May 04, 2020 (GLOBE NEWSWIRE) —  Green Plains Inc. (NASDAQ:GPRE) today announced financial results for the first quarter of 2020. Net loss attributable to the company was $16.4 million, or $(0.47) per diluted share, for the first...

Continue reading

Denny’s Corporation Provides Business Update and Announces Timing of First Quarter Results and Conference Call on May 14, 2020

SPARTANBURG, S.C., May 04, 2020 (GLOBE NEWSWIRE) — Denny’s Corporation (NASDAQ: DENN), franchisor and operator of one of America’s largest franchised full-service restaurant chains, today provided a business update on the impact of the COVID-19 pandemic on the Company’s operations and certain other preliminary financial information ahead of its first quarter earnings announcement planned for May 14, 2020.Business UpdateSalesThe COVID-19 pandemic and various related government mandates restricting dine-in restaurant service have continued to disrupt domestic and international operations for Denny’s Corporation and its franchisees.  First quarter 2020 domestic system-wide same-store sales1 declined 6.3% as compared to the first quarter of 2019.  Preliminary results for domestic system-wide same-store sales1 for April 2020 reflect...

Continue reading

SCI Engineered Materials, Inc. Reports First Quarter 2020 Results   

COLUMBUS, Ohio, May 04, 2020 (GLOBE NEWSWIRE) — SCI Engineered Materials, Inc. (“SCI”) (SCIA: OTCQB), a global supplier and manufacturer of advanced materials for physical vapor deposition thin film applications who works closely with end users and OEMs to develop innovative, customized solutions, today reported financial results for the three months ended March 31, 2020.The Company continues to receive orders for its products, although some shipments have been impacted by temporary closure of customer facilities due to the COVID-19 global pandemic. During the second quarter of 2020, and perhaps longer, we may operate below our normal production schedule.Jeremy Young, President and Chief Executive Officer, stated, “Our first quarter 2020 results were profitable. We continue to value our employees and appreciate their contributions...

Continue reading

GCP Applied Technologies Files Investor Presentation Highlighting Significant Board Refreshment, Progress on Strategy and Enhanced Results

Mails Letter to Shareholders Underscoring GCP’s Numerous Attempts and Actions to Seek an Appropriate Outcome on Behalf of ALL Shareholders in Connection with Starboard Proxy ContestGCP Urges Shareholders to Vote “FOR” ALL Its Director Nominees on the BLUE Proxy CardCAMBRIDGE, Mass., May 04, 2020 (GLOBE NEWSWIRE) — GCP Applied Technologies Inc. (NYSE:GCP) (“GCP” or the “Company”), a leading global provider of construction products technologies, today announced that it has issued an investor presentation in connection with its 2020 Annual Meeting of Stockholders (“2020 Annual Meeting”).The presentation is available at https://investor.gcpat.com/proxy-materials-and-stockholder-communications. Highlights of the presentation include:   •  GCP’s Board and management are taking decisive actions to deliver value to GCP shareholdersFocused...

Continue reading

Presentation Regarding Apergy’s Planned Merger with ChampionX Posted on Apergy’s Website

THE WOODLANDS, Texas, May 04, 2020 (GLOBE NEWSWIRE) — Apergy Corporation (“Apergy”) (NYSE: APY) today posted a presentation regarding its planned merger with ChampionX to its website to coincide with a meeting for equity research analysts on the combined company. The presentation is available at https://investors.apergy.com/events-and-presentations/presentations.About ApergyApergy is a leading provider of highly engineered equipment and technologies that help companies drill for and produce oil and gas safely and efficiently around the world. Apergy’s products provide efficient functioning throughout the lifecycle of a well – from drilling to completion to production. Apergy’s Production & Automation Technologies offerings consist of artificial lift equipment and solutions, including rod pumping systems, electric...

Continue reading

IZEA Announces “BrandGraph® for COVID-19 Competitive Intelligence” Streaming Event

Orlando, Florida, May 04, 2020 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), operator of IZEAx®, the premier online marketplace connecting brands and publishers with influential content creators, today announced a streaming event to demonstrate the latest capabilities of BrandGraph®, its newly released social intelligence platform.Join IZEA’s Founder and CEO, Ted Murphy, as he provides an overview of the BrandGraph platform, which analyzes the content of more than 4 million social media influencers to garner insights for marketers and brands of all sizes. The platform recently reached a significant milestone of analyzing and enriching more than 500 million pieces of content, while continuing to add new content insights every 10 seconds.BrandGraph provides analysis of share-of-voice, engagement benchmarking, category...

Continue reading

Endonovo Therapeutics Announces Positive 2019 Fiscal Results

Los Angeles, CA, May 04, 2020 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”) today reported financial results for fiscal year ended December 31, 2019.Key Financial Highlights:Revenues for the year ended December 31, 2019 increased by 273% to $310,164, as compared to $83,263 in the fiscal year for 2018.Gross Profit increased 208% to $216,779 in 2019, as compared to $70,333 in the fiscal year for 2018.Alan Collier, Chief Executive Officer of Endonovo, commented, “During 2019, we launched SofPulse®’s, a FDA cleared medical device, national marketing and distribution roll out. The results we experienced from our efforts resulted in positive gains in revenue and distribution in our first year of commercialization. Through our marketing efforts, we have been able to effectively...

Continue reading

Isoray To Announce Third Quarter Fiscal 2020 Financial Results on May 12, 2020

RICHLAND, Wash., May 04, 2020 (GLOBE NEWSWIRE) —  Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financial results for the third quarter fiscal 2020 ended March 31, 2020 on Tuesday, May 12, 2020, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the third quarter fiscal 2020 after the close of the U.S. stock markets on May 12, 2020. To listen to the conference call, please dial 844-602-0380. For callers outside the U.S., please dial 862-298-0970.The conference call will be simultaneously webcast and can be accessed at https://www.webcaster4.com/Webcast/Page/2199/34448 by clicking on the link. The webcast will...

Continue reading

Corbus Pharmaceuticals to Report First Quarter Results on May 11, 2020

– Management to host conference call and webcast on Monday, May 11 at 8:30 a.m. ET-NORWOOD, MA, May 04, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that it will report its first quarter financial results on Monday, May 11. Corbus management will host a conference call and live audio webcast to discuss operational and financial results at 8:30 a.m. ET that same day.The call will be led by Yuval Cohen, Ph.D., Chief Executive Officer of Corbus. He will be joined by additional members of the Corbus management team. Interested participants and investors may access the conference call by dialing (877) 407-3978 (domestic) or (412) 902-0039...

Continue reading

Catalyst Pharmaceuticals to Hold First Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 12th, 2020

CORAL GABLES, Fla., May 04, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced that it will release first quarter 2020 financial results after market close on Monday, May 11, 2020. Further, Catalyst management will host an investment-community conference call at 8:30 a.m. ET on Tuesday, May 12, 2020 to discuss the financial results and to provide a corporate update.Investors who wish to participate in the conference call may do so by dialing (877) 407-8912 for domestic and Canadian callers or (201) 689-8059 for international callers. Those interested in listening to the conference call live via...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.